disease

The U.S. Food and Drug Administration has approved Exelixis Inc.’s (NASDAQ:EXEL) Cabometyx (cabozantinib) for two indications in adult and pediatric patients with previously treated, unresectable, locally advanced or metastatic, well-differentiated pancreatic and extra-pancreatic...

Stifel initiated coverage on Monday on Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. Crinetics’ lead development...

Johnson & Johnson (NYSE:JNJ) just hit a Golden Cross, a classic bullish technical pattern that signals potential long-term upside. The stock's 50-day simple moving average crossed above its 200-day simple moving average, often seen as a sign of strengthening momentum. While the charts suggest...

Regenxbio Inc (NASDAQ:RGNX) revealed on Wednesday new interim data from two additional patients in the Phase 1/2 portion of the AFFINITY DUCHENNE trial of RGX-202, an investigational gene therapy for Duchenne muscular dystrophy. Results were presented at the 2025 Muscular Dystrophy Association (MDA...

AbbVie Inc (NYSE:ABBV) released on Saturday the final analysis of the confirmatory Phase 3 MIRASOL trial of Elahere (mirvetuximab soravtansine-gynx) in women with folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC) compared to chemotherapy. The U.S. Food and Drug...

Avidity Biosciences, Inc. (NASDAQ:RNA) released on Monday del-zota topline data from the Phase 1/2 EXPLORE44 trial in people living with Duchenne muscular dystrophy amenable to exon 44 skipping (DMD44). Del-zota is designed to deliver phosphorodiamidate morpholino oligomers (PMOs) to skeletal and...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) released on Monday data from the first three of five potential cohorts of its ongoing Phase 1 dose escalation trial of PLN-101095, in combination with Merck & Co Inc.’s (NYSE:MRK) Keytruda (pembrolizumab), in patients with immune...

Scholar Rock Holding Corp. (NASDAQ:SRRK) said on Sunday the company will present new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference. The Phase 3 SAPPHIRE trial evaluated the efficacy and safety...

H.C. Wainwright & Co. initiated coverage on Thursday for Perspective Therapeutics, Inc. (NASDAQ:CATX), a clinical-stage biotechnology company advancing “targeted radiotherapy agents” for cancer treatment. Analyst Robert Burns initiated a Buy rating and a price target of $10. The...

"We got really lucky about six years ago when we started exploring how cannabinoids might be used to treat drug-resistant infections," says Dr. Dana Lambert, CEO of Andira Pharmaceuticals, in an exclusive interview with Benzinga. Dr. Lambert doesn't speak like an academic. Despite holding a Ph.D....

According to the latest data from the Centers for Disease Control and Prevention, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus. The virus was confirmed on Friday at a commercial poultry production facility in Georgia, the...

In a court filing on Monday, the Department of Health and Human Services (HHS) challenged Vertex Pharmaceuticals Inc (NASDAQ:VRTX), defending its stance that the company’s proposed fertility services program would breach anti-kickback laws. The program is tied to Vertex’s gene-editing...

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC) and Crohn’s disease (CD). In the RELIEVE UCCD study, 36.2% (low-dose) and 47.8% (high-dose) of patients with...

GeoVax Labs Inc (NASDAQ:GOVX) shares popped ahead of the close on Wednesday and continue to bounce around in extended trading following a report suggesting Michigan’s Wayne County confirmed its first case of mpox since 2022. What Happened: According to a Fox Detroit report, the Wayne County...

The U.S. Food and Drug Administration (FDA) may approve updated COVID-19 vaccines this week to combat recent strains as the country endures its most significant summer outbreak in two years. The FDA is expected to give the nod to updated mRNA vaccines from Moderna, Inc. (NASDAQ:MRNA) and Pfizer Inc...